Paris-based startup Bioptimus has secured a €35M seed investment led by Sofinnova Partners.

The funding round included participation from AI startup Owkin, among other backers.

Bioptimus is utilizing talent from former Google DeepMind to push the boundaries of biology research with AI.

A technical partnership with Owkin grants Bioptimus access to patient data from academic hospitals.

The startup's ambitious goal is to create the 'first universal AI foundation model for biology'.

Bioptimus's research will be powered by a compute environment hosted on Amazon Web Services.

The company's AI-driven research could illuminate the aging process and advance personalized medicine, biomedical, and environmental sciences.